FDA Gastrointestinal Drugs Advisory Committee
Executive Summary
On July 25, the committee will discuss SmithKline Beecham's Tagamet (cimetidine) as a continuous I.V. for treatment of stress ulcers. The committee will also discuss "A Draft Guideline for the Study of Crohn's Disease." On July 26, the committee will discuss the use of bismuth subsalicylate (Procter & Gamble's Pepto-Bismo) as a Category / OTC antidiarrheal. Both days' meetings will be from 9 a.m. to 5 p.m. at Parklawn, conference rooms D&E.